ScreenerHero

ATXIAvenue Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · avenuetx.com
0.2500USD0.00%Mkt Cap: 848783 $P/E: —

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include ATX-04, a smal…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap848.78K $
Enterprise Value-1.09M $
Revenue (TTM)0 $
Gross Profit0 $
Net Income (TTM)-2.91M $
Revenue/Share0.0000 USD
Last Price0.2500 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.08
PEG—
EV/EBITDA—
EV/Revenue—
P/SInfinity
P/B1.49
EPS (TTM)-0.86
EPS (Forward)-3.14
52W Range
0.150012% of range0.9699
52W High0.9699 USD
52W Low0.1500 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-207.19%
ROE-158.79%
ROA-99.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.83M $
CapEx (TTM)—
FCF Margin—
FCF Yield-74.40%
Net Debt-1.94M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.40
Quick Ratio1.38
Book Value/Sh0.1730 USD
Cash/Share0.5890 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:75
Split DateApr 26, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.29M
Float2.85M
Insiders13.51%
Institutions7.02%
Short Interest
Short Ratio0.7d
Short % Float2.83%
Short % Out.2.83%
Shares Short59.70K
Short (prev mo.)154.91K
Technical
SMA 500.2951 (-15.3%)
SMA 2000.4162 (-39.9%)
Beta-0.20
S&P 52W Chg18.16%
Avg Vol (30d)899
Avg Vol (10d)1.32K
Technical Indicators
RSI (14)46.5
MACD-0.0105
MACD Signal-0.0096
MACD Hist.-0.0009
BB Upper0.3333 USD
BB Middle0.2668 USD
BB Lower0.2004 USD
BB Width49.81%
ATR (14)0.0339 USD
Vol Ratio (20d)0.00x